Form DEFR14A - Revised definitive proxy soliciting materials
16 December 2024 - 10:30PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
(Rule
14a-101)
INFORMATION
REQUIRED IN PROXY STATEMENT
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary
Proxy Statement |
☐ |
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ |
Definitive
Proxy Statement |
☐ |
Definitive
Additional Materials |
☐ |
Soliciting
Material Pursuant to §240.14a-12 |
AGEAGLE
AERIAL SYSTEMS INC.
(Name
of Registrant as Specified in Its Charter)
(Name
of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
☒
No fee required.
☐
Fee paid previously with preliminary materials.
☐
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
AMENDMENT
NO. 1 TO THE PROXY STATEMENT
DATED
NOVEMBER 19, 2024 FOR THE
SPECIAL
MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 20, 2022
EXPLANATORY
NOTE
This
amendment (“Amendment No. 1”) amends and supplements the definitive proxy statement of AgEagle Aerial Systems Inc. (the “Company”)
filed with the Securities and Exchange Commission on November 19, 2024 (the “Proxy Statement”). The Proxy Statement relates
to the Company’s Special Meeting of Shareholders (the “Special Meeting”), which will be held as a virtual meeting on
December 20, 2024, at 11:00 a.m., Eastern Time, at https://web.viewproxy.com/uavs/2024.
This
Amendment No. 1 corrects the number of shares outstanding as of the Record Date. We incorrectly disclosed the number of shares of our
Common Stock outstanding and entitled to vote in the sections of the Proxy Statement entitled (i) “General Information About Voting”
under the question “Who is entitled to vote at the Special Meeting?” and (ii) “Description of the Amendment”
(collectively, the “Corrected Sections”). The correct number of shares of our Common Stock outstanding as of the Record Date
and entitled to vote at the Special Meeting is 3,554,096 (versus 4,378,308 as originally reported in the Proxy Statement). Accordingly,
each Corrected Section is amended and restated as follows:
Who
is entitled to vote at the Special Meeting?
Only
shareholders of record at the close of business on November 8, 2024 (the “Record Date”) will be entitled to vote at
the Special Meeting. As of the Record Date, 3,554,096 shares of the Common Stock were outstanding and entitled to vote. Each share
of Common Stock outstanding on the Record Date is entitled to one vote on each proposal.
Description
of the Amendment
As
of November 8, 2024 (the “Record Date”), our current authorized capital stock of 30,000,000 consisted of 5,000,000
shares of Common Stock, of which 3,554,096 shares were outstanding, and 25,000,000 shares of preferred stock, par value $0.001,
of which 1,764 shares have been designated as our Series B Preferred Stock, 10,000 shares have been designated as our Series C Preferred
Stock, 2,000 shares have been designated as our Series D Preferred Stock, and 35,000 shares have been designated as our Series F Preferred
Stock. As of the Record Date, no shares of our Series B Preferred Stock, Series C Preferred Stock, or Series D Preferred Stock were issued
and outstanding, while 4,295 shares of our Series F Preferred Stock were issued and outstanding. As of the Record Date, the following
additional securities are outstanding: (i) 7,380 shares of our Common Stock that are issuable upon exercise of outstanding options and
restricted stock units, (ii) 222,589 additional shares of our Common Stock that are reserved for issuance under the Company’s 2017
Omnibus Equity Incentive Plan, (iii) 3,966,683 shares of our Common Stock that are issuable upon exercise of Series A Warrants outstanding,
(iv) 2,550,133 shares of our Common Stock that are issuable upon exercise of Series B Warrants outstanding; (v) 174,807 shares of our
Common Stock that are issuable upon exercise of warrants outstanding; and (vi) 2,674,724 shares issuable upon the conversion of convertible
Series F Preferred Stock.
Under
the terms of the Amendment, the total number of authorized shares of capital stock will be increased to 195,000,000. The number of shares
of Common Stock authorized will be increased to 200,000,000. The number of shares of preferred stock will remain unchanged at 25,000,000.
The newly authorized shares of Common Stock will be identical to previously authorized shares of Common Stock and will entitle the holders
thereto to the same rights and privileges as holders of the previously authorized shares.
Except
as specifically discussed in this Explanatory Note, this Amendment No. 1 does not otherwise modify or update any other disclosures presented
in the Proxy Statement. In addition, this Amendment No. 1 does not reflect events occurring after the date of the Proxy Statement or
modify or update disclosures that may have been affected by subsequent events. Capitalized terms that are not defined in this Amendment
No. 1 have the meanings set forth in the Proxy Statement.
AgEagle Aerial Systems (AMEX:UAVS)
Historical Stock Chart
From Nov 2024 to Dec 2024
AgEagle Aerial Systems (AMEX:UAVS)
Historical Stock Chart
From Dec 2023 to Dec 2024